Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

BOVNF
BIOINVENT INTL NEW
stock OTC

Inactive
Dec 9, 2020
0.2000USD-4.762%(-0.0100)2,500
Pre-market
0.00USD-100.000%(-0.21)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Apr 29, 2021
05:50AM EDT  Resolutions at BioInvent's Annual General Meeting 2021   PR Newswire
Apr 12, 2021
01:42AM EDT  BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric   PR Newswire
Apr 8, 2021
02:51AM EDT  BioInvent International's Annual Report 2020 published   PR Newswire
Mar 31, 2021
02:49AM EDT  Change in the number of shares and votes in BioInvent International AB   PR Newswire
Mar 11, 2021
03:07AM EST  BioInvent presents proof-of-concept data on anti-FcyRIIB antibody BI-1607 at   PR Newswire
Mar 1, 2021
02:00AM EST  BioInvent And Transgene Enrol First Patient In Phase I/IIa Trial Of Novel Oncolytic Virus BT-001 In Solid Tumors   RTTNews
01:53AM EST  BioInvent and Transgene has enrolled first patient in Phase I/IIa trial of   PR Newswire
Feb 23, 2021
03:21AM EST  BioInvent International Financial Statement January 1 - December 31, 2020   PR Newswire
Jan 28, 2021
02:24AM EST  BioInvent Phase I/IIa Data Show BI-1206 Restores Activity Of Rituximab In Relapsed Non-Hodgkin's Lymphoma Patients   RTTNews
02:02AM EST  BioInvent Phase I/IIa data suggest BI-1206 restores activity of rituximab in   PR Newswire
Dec 21, 2020
02:56AM EST  BioInvent and Transgene receive CTA approval for Phase l/lla trial of oncolytic   PR Newswire
Dec 9, 2020
03:10AM EST  Nomination Committee appointed for BioInvent International's Annual General   PR Newswire
Nov 27, 2020
04:09AM EST  BioInvent strengthens Investor Relations   PR Newswire
Nov 26, 2020
02:54AM EST  BioInvent And Cantargia Sign Manufacturing Deal For Monoclonal Antibody CAN10   RTTNews
02:51AM EST  BioInvent and Cantargia sign manufacturing agreement for monoclonal antibody   PR Newswire
Oct 29, 2020
03:16AM EDT  BioInvent Interim Report January 1 - September 30, 2020   PR Newswire
Oct 27, 2020
04:36AM EDT  Notice to Extraordinary General Meeting in BioInvent International AB   PR Newswire
Aug 21, 2020
07:05AM EDT  Invitation to presentation of BioInvent's second quarter report 2020 on August   PR Newswire
Jul 22, 2020
03:33AM EDT  BioInvent's BI-1206 could improve treatment in several cancers   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC